Introduction {#s1}
============

Cardiovascular disease (CVD) is the leading cause of mortality in Western populations. It is also known that the life-long risk for CVD is higher for men than women [@pone.0063347-Vaartjes1], [@pone.0063347-Mosca1]. In the last few decades this difference has somewhat narrowed due to a decrease in male, and an increase in female risk [@pone.0063347-Towfighi1]. Age is the most significant determinant for CVD in both sexes, but the data are not uniform as regards the sex differences in CVD risk by age. A large body of epidemiological evidence supports the concept that in postmenopausal years the female risk for CVD elevates more rapidly than among same-aged men [@pone.0063347-Kannel1]--[@pone.0063347-Joakimsen1] while equally strong data dispute this difference [@pone.0063347-BarrettConnor1], [@pone.0063347-Vaidya1]. These contradicting results may be partly explained by methodological differences, e.g. in statistical analyses used. Moreover, the picture is further blurred with data that early menopause, either spontaneous or artificial, is accompanied with an elevation in age-adjusted risk for CVD in most [@pone.0063347-Atsma1], but not all [@pone.0063347-Tom1] studies.

Finland is known for the high rate of CVD mortality [@pone.0063347-Vartiainen1], and indeed, the age-standardized mortality from CVD is 62% higher for Finnish men (179 vs. 110 per 100 000 men) and 43% higher for Finnish women (80 vs. 56 women per 100 000 women) than the respective average of European Union [@pone.0063347-Eurostat1]. The Finnish population is rather homogenous, as regards to race, standard of living and healthcare. Furthermore, a comprehensive and accurate register includes data for causes of death throughout the country. All this enabled us to explore the sex differences in annual age-adjusted mortality for CVD in Finland between years 1986--2009.

Materials and Methods {#s2}
=====================

A total of 1 080 910 deaths from diseases and medical conditions reported to the Finnish nationwide Causes of Death Register in 1986--2009 were analyzed ([Table 1](#pone-0063347-t001){ref-type="table"}). This register is based on the law and diagnoses are imported from death certificate undersigned by a physician and double-checked by medical experts at regional level and at Statistics Finland. The register is accurate, and particularly so for deaths due to CVD, as shown before [@pone.0063347-Rapola1], [@pone.0063347-Pajunen1]. It is noteworthy that if the cause of death is not fully verified by clinical history or pre-mortal findings from specific examinations (e.g. electrocardiograms, laboratory), an autopsy is advocated; this occurs in approximately 31% of all deaths [@pone.0063347-Pajunen1]. We used the European causes-of-death shortlist produced by Eurostat (2012) to define causes-of-death [@pone.0063347-European1]. We focused on deaths from vascular diseases classified into ICD-9 codes 390--459, and into ICD-10 codes as I00--99, further divided into ischemic heart diseases (ICD-9∶410--414 and ICD-10: I20--I25, cerebrovascular diseases (430--438 and I60--I69) and other, non-vascular heart diseases 420--423+425--429 and I30--I33+I39--I52). Deaths from diseases and medical conditions, which were unrelated to cardiovascular system, were considered as one single group of non-vascular deaths.
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###### Overall mortality among men and women, Finland 1986--2009.

![](pone.0063347.t001){#pone-0063347-t001-1}

                              Men per 100 000   Women per 100 000   *p*                                 
  -------------------------- ----------------- ------------------- ------ --------- ----- ----- ------- ---------
  Vascular diseases, total        247 942              412          614    278 752   441   385   0.022   \<0.001
  Cardiovascular diseases         181 117              301          442    178 014   282   246   0.120   \<0.001
  Cerebrovascular diseases        46 866               78           122    74 991    119   104   0.001    0.154
  Other vascular diseases         19 959               33            51    25 747    41    36    0.549    0.243
  Non-vascular diseases           270 237              449          646    283 979   449   401   0.993   \<0.001
  Total                           518 179              862          1260   562 731   890   786   0.023   \<0.001

Age-standardized according to Nordic Standard Population (18).

The annual mortality rates were calculated for each of the selected cause-of-death category per 100 000 mid-year population, separately for men and women in 5-year age categories. We used the Nordic Standard Population [@pone.0063347-The1] for calculating age-standardized mortality rates for both sexes. Sex differences were tested by using the test for relative proportions. We calculated the gradient for logarithmic mortality rates in different mortality groups for both sexes, separately for age groups below and above 55--59 years. Moreover, the differences of age-related differences in mortality for CVD and non-vascular diseases in men and women were analyzed by using Joinpoint Regression Program Version 4.0.1. The statistical significance level was set at p\<0.05.

Results {#s3}
=======

The age-standardized risk for CVD death in men (442/100 000) was 79.6% higher than the respective risk in women (246/100 000) ([Table 1](#pone-0063347-t001){ref-type="table"}). The male dominance in overall ([Table 2](#pone-0063347-t002){ref-type="table"}), CVD ([Table 3](#pone-0063347-t003){ref-type="table"}) and non-vascular ([Table 4](#pone-0063347-t004){ref-type="table"}) mortality was seen in all adult age groups. The CVD mortality was highest (approximately 6-fold) between 45--59 years of age ([Table 3](#pone-0063347-t003){ref-type="table"}). The male dominance diminished gradually with advancing age; the male risk was only 1.24 times higher in ages 85 years or more. The sex difference, however, remained statistically significant for all age groups above 50 years.
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###### Overall mortality among men and women by age, Finland 1986--2009.

![](pone.0063347.t002){#pone-0063347-t002-2}

             Men     Women                             
  -------- -------- -------- --------- -------- ------ ---------
  0         3 339     452      2 580     365     1,24    0,462
  1--4       467       16       417       15     1,07    0,986
  5--9       336       9        308       8      1,13    0,994
  10--14     340       9        288       8      1,13    0,985
  15--19     581       15       387       10     1,50    0,931
  20--24     951       23       576       15     1,53    0,865
  25--29    1 373      33       763       19     1,74    0,785
  30--34    2 666      61      1 320      31     1,97    0,549
  35--39    5 317     115      2 520      57     2,02    0,221
  40--44    9 814     204      4 508      97     2,10    0,022
  45--49    15 786    346      7 254     163     2,12   \<0.001
  50--54    23 716    566     10 662     256     2,21   \<0.001
  55--59    34 237    920     14 848     387     2,38   \<0.001
  60--64    46 614   1 494    21 638     629     2,38   \<0.001
  65--69    59 493   2 399    33 342    1 080    2,22   \<0.001
  70--74    73 984   3 866    54 184    1 948    1,98   \<0.001
  75--79    84 285   6 256    87 049    3 655    1,71   \<0.001
  80--84    76 932   10 016   117 249   6 819    1,47   \<0.001
  85--89    50 926   15 900   113 694   12 313   1,29   \<0.001
  90--94    21 740   24 653   67 163    20 946   1,18   \<0.001
  95--      5 282    37 602   21 981    33 203   1,13   \<0.001

10.1371/journal.pone.0063347.t003

###### Mortality from cardiovascular diseases among men and women by age, Finland 1986--2009.

![](pone.0063347.t003){#pone-0063347-t003-3}

             Men     Women                            
  -------- -------- -------- -------- -------- ------ ---------
  0           23       3        24       3      0,92    0,998
  1--4        14       0        18       1      0,75    0,998
  5--9        16       0        11       0      1,39    0,998
  10--14      19       0        15       0      1,21    0,999
  15--19      49       1        21       1      2,23    0,989
  20--24      87       2        36       1      2,31    0,981
  25--29     127       3        43       1      2,82    0,969
  30--34     362       8       105       3      3,30    0,906
  35--39     982       21      187       4      5,03    0,72
  40--44    2 370      49      357       8      6,40    0,371
  45--49    4 519      99      657       15     6,71    0,076
  50--54    7 775     186     1 169      28     6,62    0,001
  55--59    12 314    331     2 151      56     5,89   \<0.001
  60--64    17 652    566     4 408     128     4,41   \<0.001
  65--69    22 863    922     8 957     290     3,18   \<0.001
  70--74    27 214   1 422    16 801    604     2,35   \<0.001
  75--79    30 276   2 247    29 232   1 228    1,83   \<0.001
  80--84    27 321   3 557    41 357   2 405    1,48   \<0.001
  85--89    17 596   5 494    40 789   4 417    1,24   \<0.001
  90--94    7 629    8 651    23 881   7 448    1,16   \<0.001
  95--      1 909    13 590   7 795    11 775   1,15   \<0.001

10.1371/journal.pone.0063347.t004

###### Mortality from non-vascular diseases among men and women by age, Finland 1986--2009.

![](pone.0063347.t004){#pone-0063347-t004-4}

             Men     Women                            
  -------- -------- -------- -------- -------- ------ ---------
  0         3 309     448     2 552     361     1,24    0,463
  1--4       450       15      393       14     1,07    0,982
  5--9       314       8       287       8      1,00    0,994
  10--14     304       8       262       7      1,14    0,988
  15--19     505       13      335       9      1,44    0,939
  20--24     807       20      476       12     1.67    0,88
  25--29    1 136      27      630       16     1,69    0,821
  30--34    2 059      47     1 086      26     1,81    0,667
  35--39    3 800      82     2 037      46     1,78    0,446
  40--44    6 503     135     3 641      79     1,71    0,223
  45--49    9 799     215     5 856     131     1,64    0,079
  50--54    13 844    331     8 397     201     1,65    0,008
  55--59    18 754    504     11 146    291     1,73   \<0.001
  60--64    24 152    774     14 677    427     1,81   \<0.001
  65--69    29 705   1 198    19 693    638     1,88   \<0.001
  70--74    36 869   1 927    28 533   1 026    1,88   \<0.001
  75--79    41 579   3 086    41 514   1 743    1,77   \<0.001
  80--84    37 646   4 901    52 235   3 038    1,61   \<0.001
  85--89    25 326   7 907    49 810   5 394    1,47   \<0.001
  90--94    10 780   12 225   30 227   9 427    1,30   \<0.001
  95--      2 596    18 481   10 192   15 395   1,20   \<0.001

The CVD and non-vascular mortality curves expressed on a logarithmic scale for men were parallel (p = 0.065), whereas for women the CVD mortality showed a steeper increase (p\<0.001). The CVD mortality in both sexes demonstrates significant changes at mid-life ([Figures 1A and 1B](#pone-0063347-g001){ref-type="fig"}). The increase in CVD mortality rate for men slow down after age of 40 years ([Figure 1A](#pone-0063347-g001){ref-type="fig"}), while for women the increase in the curve accelerates from age of 60 years and above ([Figure 1B](#pone-0063347-g001){ref-type="fig"}). Age groups 55 to 59 are the cutting points for sex-related CVD mortality; for men at ages 20 to 59 the slope for the logarithmic increase in risk of dying of CVD is 0.066 while at ages 55 and over the slope is 0.040 demonstrating a decrease in risk for CVD mortality. Instead, for women belonging to age groups 20 to 59 the slope for the logarithmic increase in the risk for CVD mortality is 0.053 while at ages 55 and over the slope is 0.058 demonstrating an increase in risk for CVD mortality. In contrast, the curves for non-vascular deaths are similar for both sexes ([Figures 1A and 1B](#pone-0063347-g001){ref-type="fig"}). A shift for female dominance is also seen when the CVD mortality in a given 5 year-periods is expressed as percentage increase from the mortality during preceding 5 years of age ([Figure 2](#pone-0063347-g002){ref-type="fig"}).

![Mortality rates for cardiovascular diseases and non-vascular diseases in five-year age categories expressed on a logarithmic scale.](pone.0063347.g001){#pone-0063347-g001}

![Male and female mortality for cardiovascular diseases in a given 5 year-period expressed as percentage increase from the mortality during preceding 5 years of age.](pone.0063347.g002){#pone-0063347-g002}

Discussion {#s4}
==========

We analyzed more than one million deaths of which approximately one half were classified as CVD deaths. The data covered whole Finland during 24 consecutive years (1986--2009). It is evident from our data that the male age-adjusted CVD mortality is higher than the female mortality throughout life. This difference is most conspicuous at 40--44 years of age. However, after 55--59 years of age the female age-specific CVD mortality increases significantly more rapidly than the mortality for non-vascular causes, while in men, the CVD and non-vascular mortality curves are parallel. This results in a significant difference in the behavior of age-adjusted CVD mortality between men and women after 60--64 years of age.

The CVD mortality was much smaller in women than men of less than 45 years of age in Finland. These data are in line with previous ones from other countries [@pone.0063347-Mosca1]--[@pone.0063347-Kannel1]. This difference has been largely attributed to circulating estrogens present in women of fertile age. This explanation can be supported by epidemiological data that early menopause occurring spontaneously or as a result of bilateral oophorectomy is associated with 4--7--fold elevation in the risk for CVD [@pone.0063347-Atsma1]. However, other explanations for high male CVD mortality at young ages may well exist. It is a fact that various CVD risk factor, such as smoking, heavy drinking or poor dietary habits accumulate in young men, perhaps to the degree that CVD ensues [@pone.0063347-Vartiainen1]. It is also possible that various genes regulating e.g. insulin resistance and body fat distribution predispose preferably men to a risk for vascular disease [@pone.0063347-Charchar1], [@pone.0063347-McCarthy1]. A sex difference may also exist in telomerase activity, which may endanger the tissue reparative capacity in men [@pone.0063347-Benetos1]. It remains open, however, why this defect should occur only in cardiovascular system and not in other organs; mortality for other than CVD causes showed only linear age- dependence.

There have been opposing interpretations whether CVD mortality is truly increased in women after menopause. Long-term follow-up data imply that menopause is followed by an increase in CVD mortality [@pone.0063347-Kannel1], [@pone.0063347-Hu1], [@pone.0063347-vanderSchouw1], [@pone.0063347-Mondul1], whereas some cross-sectional mortality data analyses dispute this change [@pone.0063347-BarrettConnor1], [@pone.0063347-Vaidya1], [@pone.0063347-TunstallPedoe1]. One possible explanation may be the overrepresentation of women in older age groups, which may exaggerate the mortality figures, especially if non-logarithmic calculations are employed. Furthermore, women live longer than men in western world, and therefore, eventually more women than men die of CVD [@pone.0063347-Mosca1], [@pone.0063347-Roger1]. Our analyses indicate that age-standardized CVD mortality increases significantly after 60 years of age in women while the mortality for non-vascular diseases increases linearly with advancing age. We cannot deduce the reason(s) behind this phenomenon, but of course, menopause-induced hypoestrogenism is one possibility [@pone.0063347-Vitale1], [@pone.0063347-Lin1]. If endogenous or exogenous estrogen mediates CVD protection it would be likely to be manifest at a young age and early menopause, but not anymore if initiated among women aged 60 years or more, as shown by the Women's Health Initiative study [@pone.0063347-Rossouw1]. In line with this assumption, we detected a significant elevation in the female CVD mortality at this age.

Our study has limitations. First, we do not have data on any other demographic characteristics than age and sex, and thus, we could not adjust mortality for factors, such as menopausal status, hormone and other therapy, socioeconomic status, smoking or body weight. We did the analysis separately for different periods of time and by five university hospital regions, and the results were similar to those shown here. Second, one can argue that CVD morbidity rather than mortality should have been studied. It is, however, known that CVD mortality closely reflects CVD morbidity [@pone.0063347-Mosca1], and therefore our data are likely representative for the general CVD occurrence. And finally, our analysis was conducted in racially homogenous Finnish population and thus, it is questionable how well our data can be applied to other populations with different ethnic backgrounds.

Our study also has several strengths. First, our data included over million deaths from consecutive 24-year period. Second, our Cause-of-Death Register covers the entire country and is accurate [@pone.0063347-Lahti1]. It should be noted that high standard health care provides accurate pre-mortal medical data, which facilitate reliable death diagnosis, and if not fully clear based on the pre-mortal data, autopsies are frequently carried out. And third, although CVD mortality in Finland has somewhat declined during the past decades [@pone.0063347-Vartiainen1], [@pone.0063347-Lehto1] it is still among the highest in Europe, and therefore, possible sex-specific differences in CVD mortality might be revealed in this population.

In summary, we show that there are sex-related differences in CVD mortality. While men have acceleration in heart diseases mortality at relatively young age, in women this risk shows a steep increase at approximately 60 years of age. This is likely a consequence of risk factors appearing some 10--20 years earlier. Therefore, it is highly important to improve CVD risk factors, in women already at fertile age as well as in their mid-life years.
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